Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 31INDUSTRY 6NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 265Breast Neoplasms, Male 20Breast Carcinoma In Situ 15Carcinoma, Non-Small-Cell Lung 13Prostatic Neoplasms 12Carcinoma, Intraductal, Noninfiltrating 12Neoplasm Metastasis 11Lung Neoplasms 11Carcinoma, Ductal, Breast 11Pain 9Colorectal Neoplasms 9Colonic Neoplasms 9Neoplasms 8Inflammatory Breast Neoplasms 8Osteoporosis 7Carcinoma, Ovarian Epithelial 7Triple Negative Breast Neoplasms 6Ovarian Neoplasms 6Fatigue 6Small Cell Lung Carcinoma 5Rectal Neoplasms 5Testicular Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Sezary Syndrome 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Mycosis Fungoides 4Multiple Myeloma 4Melanoma 4Lymphoma, T-Cell, Cutaneous 4

Interventions

Trastuzumab 1Surgical Procedures, Operative 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Neoplastic Cells, Circulating × Breast × Clear all
NCT01015625 2024-08-19

POSYTIVE

Austrian Breast & Colorectal Cancer Study Group

Phase NA Completed
90 enrolled 16 charts
Breast

Breast Neoplasms, Neoplastic Cells, Circulating

NCT01548677 2019-03-13

TREAT-CTC

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
1,317 enrolled
Breast

Breast Neoplasms, Neoplastic Cells, Circulating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡